O-31 - Novel Vaccines and Antibodies

Co-Author(s)

• AA

  Amanda Almaguer, Bachelors

  Scientist
  Cidara Therapeutics
  San Diego, California

  Disclosure: Cidara Therapeutics, Inc. (Employee, Shareholder)
• KA

  Karin Amundson, BSc

  Senior Research Associate
  Preclinical Development
  Cidara Therapeutics
  San Diego, California

  Disclosure: Cidara Therapeutics: Shareholder
• EA

  Evan Anderson, MD

  Infectious Diseases Physician
  Pediatrics and Medicine
  Emory University, Atlanta VA Medical Center
  Atlanta, Georgia

  Disclosure: Sanofi Pasteur (Scientific Research Study Investigator)
• 

  Alexandra Bhatti, JD, MPH

  Associate Director, US Vaccine Policy Developement
  Global Vaccine Public Policy and Partnerships
  Merck
  North Wales, Pennsylvania

  Disclosure: Merck (Employee)
• AB

  Allen Borchardt, PhD

  Director
  Medicinal Chemistry
  Cidara Therapeutics
  San Diego, California

  Disclosure: Cidara Therapeutics (Employee)
• TB

  Thomas Brady, PhD Chemistry

  Principal Scientist
  Chemistry
  Cidara Therapeutics
  San Diego, California

  Disclosure: Cidara Therapeutics (Employee)
• TB

  Tom Brady, Ph.D.

  Senior Principle Scientist
  Chemistry
  Cidara Therapeutics
  San Diego, California

  Disclosure: Cidara Therapeutics (Shareholder)
• JC

  Jason Cole, PhD

  Senior Scientist
  Immunology
  Cidara Therapeutics
  San Diego, California

  Disclosure: Cidara Therapeutics (Shareholder)
• ID

  Iris De Bruijn, PhD

  Associate Vice President
  Global Clinical Development
  Sanofi Pasteur
  Marcy L'Etoile, Rhone-Alpes, France

  Disclosure: Sanofi Pasteur (Employee)
• ND

  Nicholas Dedeic, n/a

  Research associate
  Microbiology
  Cidara Therapeutics
  San Diego, California

  Disclosure: Cidara Therapeutics (Employee)
• MG

  Michelle Goveia, MD

  Director
  Medical Affairs
  Merck
  North Wales, Pennsylvania

  Disclosure: Merck & Co., Inc (Employee, Shareholder)
• YH

  Ying He, PhD

  Biostatistician
  Sanofi Pasteur
  Virginia Beach, Virginia

  Disclosure: Otsuka Pharmaceutical (Employee)Sanofi Pasteur (Other Financial or Material Support, Former employee)
• BH

  Bryony Hicks, BSc

  Regional Trial Manager
  Sanofi Pasteur
  Toronto, Ontario, Canada

  Disclosure: Sanofi Pasteur (Employee)
• GH

  Grayson Hough, MS - Chemistry

  Senior Scientist
  Cidara Therapeutics
  San Diego, California

  Disclosure: Cidara Therapeutics (Employee)
• RJ

  Robert Jeanfreau, MD

  Investigator
  MedPharmics
  Metarie, Louisiana

  Disclosure: Sanofi Pasteur (Scientific Research Study Investigator)
• RJ

  Rui Jin, PhD

  Dr.
  Microbiology
  Emory University
  Atlanta, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• RK

  Rawia Khoury, BSc

  Medical Writer
  Sanofi Pasteur
  Swiftwater, Pennsylvania

  Disclosure: Sanofi Pasteur (Employee)
• TL

  Thanh Lam, PhD

  Senior Scientist
  Chemistry
  Cidara Therapeutics
  San Diego, California

  Disclosure: Cidara Therapeutics (Shareholder)
• VL

  Victoria Landolfi, MS, MBA

  Associate Vice President
  Global Project Leadership
  Sanofi Pasteur
  Swiftwater, Pennsylvania

  Disclosure: Sanofi Pasteur (Employee)
• 

  James Levin, PhD

  Senior Director
  Preclinical Development
  Cidara Therapeutics
  San Diego, California

  Disclosure: Cidara Therapeutics: Shareholder

  Slides Slides and Audio
• ZL

  Zhiwen Liu, PhD

  Director
  Center for Observational and Real-World Evidence
  Merck & Co., Inc.
  Kenilworth, New Jersey

  Disclosure: Merck & Co., Inc., (Employee)
• JL

  Jeffrey Locke, PhD

  Director, Microbiology
  Cidara Therapeutics, Inc.
  San Diego, California

  Disclosure: Cidara Therapeutics, Inc. (Employee, Shareholder)
• AN

  Alain Noncovich, Ph.D.

  Senior Scientist II
  Chemistry
  Cidara Therapeutics
  San Diego, California

  Disclosure: Cidara Therapeutics (Shareholder)
• AP

  Aseem Pandey, PhD

  Deputy Director
  Global Clinical Immunology
  Sanofi Pasteur
  Swiftwater, Pennsylvania

  Disclosure: Sanofi Pasteur (Employee)Sanofi Pasteur (Employee)
• KS

  Kim Shathia, B.S.

  Contract Researcher
  Preclinical Development
  Cidara Therapeutics
  San Diego, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• AS

  Anju Shrestha, MD

  Director
  Global Pharmacovigilance
  Sanofi Pasteur
  Swiftwater, Pennsylvania

  Disclosure: Sanofi Pasteur (Employee)
• 

  Jakub Simon, MD, MS

  Sr. Princ. Scientist
  Merck & Co., Inc., Kenilworth, NJ, USA
  Kenilworth, New Jersey

  Disclosure: Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (Employee, Shareholder)
• CY

  Chinglai Yang, PhD

  Professor
  Microbiology
  Emory University
  Atlanta, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• QZ

  Qiping Zhao, BS

  Scientist
  Cidara
  San Diego, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presenting Author(s)

• 

  Leejah Chang, MD

  Senior Director
  Global Clinical Development
  Sanofi Pasteur
  Easton, PA

  Disclosure: Sanofi Pasteur (Employee)

  Slides Slides and Audio
• 

  Yoonyoung Choi, PhD, MS, RPh

  Associate Director
  Merck
  Philadelphia, Pennsylvania

  Disclosure: Merck (Employee)

  Slides Slides and Audio
• 

  Simon Döhrmann, PhD

  Senior Scientist
  Immunology
  Cidara Therapeutics
  San Diego, California

  Disclosure: Cidara Therapeutics (Shareholder)

  Slides Slides and Audio
• 

  James Levin, PhD

  Senior Director
  Preclinical Development
  Cidara Therapeutics
  San Diego, California

  Disclosure: Cidara Therapeutics (Shareholder)

  Slides Slides and Audio
• 

  Samuel Stampfer, MD/PhD

  Fellow
  Infectious Diseases
  Emory University
  Atlanta, Georgia

  Disclosure: Gilead (Shareholder)

  Slides Slides and Audio

Presentations:

• efficacy of CD377, a Novel Antiviral Fc-conjugate, Against Seasonal Influenza in Lethal Mouse Infection Models
  James Levin, PhD – Cidara Therapeutics; Karin Amundson, BSc – Cidara Therapeutics; Kim Shathia, B.S. – Cidara Therapeutics; Allen Borchardt, PhD – Cidara Therapeutics; Thanh Lam, PhD – Cidara Therapeutics; Tom Brady, Ph.D. – Cidara Therapeutics; Alain Noncovich, Ph.D. – Cidara Therapeutics; James Levin, PhD – Cidara Therapeutics
• Safety and Immunogenicity of Escalating Dose Formulations of High-dose Quadrivalent Influenza Vaccine in Children 6 Months Through < 18 Years of Age
  Leejah Chang, MD – Sanofi Pasteur; Evan J. Anderson, MD – Emory University, Atlanta VA Medical Center; Robert Jeanfreau, MD – MedPharmics; Ying He, PhD – Sanofi Pasteur; Bryony Hicks, BSc – Sanofi Pasteur; Anju Shrestha, MD – Sanofi Pasteur; Aseem Pandey, PhD – Sanofi Pasteur; Rawia Khoury, BSc – Sanofi Pasteur; Iris De Bruijn, PhD – Sanofi Pasteur; Victoria Landolfi, MS, MBA – Sanofi Pasteur
• impact of State Childcare and School Hepatitis a Vaccination Requirements on Coverage of Hepatitis a Vaccines in the United States
  Yoonyoung Choi, PhD, MS, RPh – Merck; Alexandra Bhatti, JD, MPH – Merck; Zhiwen Liu, PhD – Merck & Co., Inc.; Michelle Goveia, MD – Merck; Jakub Simon, MD, MS – Merck & Co., Inc., Kenilworth, NJ, USA
• CD377, a Novel Antiviral Fc-conjugate, Demonstrates Potent Viral Burden Reduction Against Influenza a (H1N1) in Mouse and Ferret Models
  Simon Döhrmann, PhD – Cidara Therapeutics; Amanda Almaguer, Bachelors – Cidara Therapeutics; Nicholas Dedeic, n/a – Cidara Therapeutics; Karin Amundson, BSc – Cidara Therapeutics; Kim Shathia, B.S. – Cidara Therapeutics; Thomas P. Brady, PhD Chemistry – Cidara Therapeutics; Alain Noncovich, Ph.D. – Cidara Therapeutics; Qiping Zhao, BS – Cidara; Grayson Hough, MS - Chemistry – Cidara Therapeutics; Allen Borchardt, PhD – Cidara Therapeutics; Jeffrey B. Locke, PhD – Cidara Therapeutics, Inc.; Jason Cole, PhD – Cidara Therapeutics; James Levin, PhD – Cidara Therapeutics
• Enhancing the Immunogenicity of a Novel, Low-cost Ebola Vaccine
  Samuel D. Stampfer, MD/PhD – Emory University; Rui Jin, PhD – Emory University; Chinglai Yang, PhD – Emory University